Rectal Cancer News

Neoadjuvant Radiation Therapy Reduces Rectal Cancer Recurrence (March 31, 2009)

Among patients with operable rectal cancer, those who received radiation therapy prior to surgery (neoadjuvant radiation therapy) had a lower risk of recurrence than those who were assigned to selective postoperative chemoradiotherapy. These results were... Continue Reading

Diet Rich in Calcium May Reduce Risk of Colorectal Cancer (March 6, 2009)

A diet that is high in calcium may be associated with a reduced risk of cancer, especially colorectal cancer, according to the results of a study published in the Archives of Internal Medicine.[1] Colorectal cancer is the second leading cause of cancer-related... Continue Reading

March Is National Colorectal Cancer Awareness Month (March 3, 2009)

March Is National Colorectal Cancer Awareness Month As the month of March brings colon cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

Test May Help Predict Recurrence Risk in Early Colorectal Cancer (February 24, 2009)

Test May Help Predict Recurrence Risk in Early Colorectal Cancer Testing lymph nodes for the presence of a protein known as guanylyl cyclase 2C (GUCY2C) may help predict risk of recurrence among colorectal cancer patients with no apparent lymph node metastases.... Continue Reading

Colorectal Cancer Screening Reduces Mortality (February 23, 2009)

Colorectal Cancer Screening Reduces Mortality The implementation of colorectal cancer screening appears to reduce mortality from the disease, as evidenced by the disparity between mortality rates among regions that implemented screening at different times.... Continue Reading

Combination of Avastin® and Erbitux® Worsens Colorectal Cancer Outcomes (February 13, 2009)

Combination of Avastin® and Erbitux® Worsens Colorectal Cancer Outcomes Among patients with previously untreated, metastatic colorectal cancer, the addition of Erbitux® (cetuximab) to Avastin® (bevacizumab) and chemotherapy resulted in shorter progression-free... Continue Reading

Aspirin and/or Resistant Starch Have No Effect on Colorectal Cancer Incidence Among People with Lynch Syndrome (February 12, 2009)

Aspirin and/or Resistant Starch Have No Effect on Colorectal Cancer Incidence Among People with Lynch Syndrome The use of aspirin and/or resistant starch has no effect on the incidence of colon cancer among individuals with Lynch Syndrome, according to... Continue Reading

Avastin® plus Fluorouracil-based Chemotherapy Effective in Elderly with Metastatic Colorectal Cancer (February 11, 2009)

Avastin® plus Fluorouracil-based Chemotherapy Effective in Elderly with Metastatic Colorectal Cancer Patients aged 65 or older with metastatic colorectal cancer benefit as much from Avastin® (bevacizumab) plus fluorouracil-based chemotherapy as their... Continue Reading

The Evolving Role of EGFR Inhibitors in Colorectal Cancer-A Report from ASCO 2008 (January 23, 2009)

The Evolving Role of EGFR Inhibitors in Colorectal Cancer-A Report from ASCO 2008 Results from the 2008 annual meeting of the American Society of Clinical Oncology (ASCO), held May 30–June 2 in Chicago, Illinois, revealed significant steps towards the... Continue Reading

The Evolving Role of EGFR Inhibitors in Colorectal Cancer-A Report from ASCO 2008 (January 23, 2009)